Advanced search
Publication Cover
Lung Cancer: Targets and Therapy Volume 8, 2017 - Issue
Submit an article Journal homepage
150
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan

Hiroshi Isobe1 Department of Medical Oncology, KKR Sapporo Medical Center, Hokkaido
,
Kiyoshi Mori2 Department of Thoracic Diseases, Division of Thoracic Oncology, Tsuboi Cancer Center Hospital, Fukushima
,
Koichi Minato3 Department of Respiratory Medicine, Gunma Prefectural Cancer Center, Gunma
,
Hideki Katsura4 Division of Respiratory Medicine, Tokyo Women’s Medical University Yachiyo Medical Center, Chiba
,
Kazuko Taniguchi5 Market Access, MSD K.K., Tokyo, Japan
,
Ashwini Arunachalam6 Center for Observational & Real World Evidence (CORE), Merck & Co., Inc., Kenilworth, NJ, USA
,
Smita Kothari6 Center for Observational & Real World Evidence (CORE), Merck & Co., Inc., Kenilworth, NJ, USACorrespondence[email protected]
,
Xiting Cao6 Center for Observational & Real World Evidence (CORE), Merck & Co., Inc., Kenilworth, NJ, USA
&
Terufumi Kato7 Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Kanagawa, Japan
 show all
Pages 191-206 | Published online: 24 Oct 2017

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mercedes L Dalurzo, Alejandro Avilés-Salas, Fernando Augusto Soares, Yingyong Hou, Yuan Li, Anna Stroganova, Büge Öz, Arif Abdillah, Hui Wan & Yoon-La Choi. (2021) Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets. OncoTargets and Therapy 14, pages 4671-4692.
Read now

Articles from other publishers (5)

Yasushi Goto, Takehito Shukuya, Ai Murata, Hironori Kikkawa, Birol Emir, Robin Wiltshire & Satoru Miura. (2023) Real‐world therapeutic effectiveness of lorlatinib after alectinib in Japanese patients with ALK ‐positive non‐small‐cell lung cancer . Cancer Science.
Crossref
Valentina Danesi, Ilaria Massa, Flavia Foca, Angelo Delmonte, Lucio Crinò, Giuseppe Bronte, Maria Ragonesi, Roberta Maltoni, Silvia Manunta, Paola Cravero, Kalliopi Andrikou, Ilaria Priano, William Balzi, Nicola Gentili, Thomas Burke & Mattia Altini. (2022) Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer. Cancers 14:18, pages 4481.
Crossref
Hiroshi Nokihara, Takashi Kijima, Toshihide Yokoyama, Hiroshi Kagamu, Takuji Suzuki, Masahide Mori, Melissa L. Santorelli, Kazuko Taniguchi, Tetsu Kamitani, Masato Irisawa, Kingo Kanda, Machiko Abe, Thomas Burke & Yasushi Goto. (2022) Real-World Treatments and Clinical Outcomes in Advanced NSCLC without Actionable Mutations after Introduction of Immunotherapy in Japan. Cancers 14:12, pages 2846.
Crossref
Frances B Maguire, Cyllene R Morris, Arti Parikh-Patel, Rosemary D Cress, Theresa H M Keegan, Chin-Shang Li, Patrick S Lin & Kenneth W Kizer. (2019) First-Line Systemic Treatments for Stage IV Non-Small Cell Lung Cancer in California: Patterns of Care and Outcomes in a Real-World Setting. JNCI Cancer Spectrum 3:3.
Crossref
Dae Ho Lee, Hiroshi Isobe, Hubert Wirtz, Sabina Bandeira Aleixo, Phillip Parente, Filippo de Marinis, Min Huang, Ashwini Arunachalam, Smita Kothari, Xiting Cao, Nello Donnini, Ann-Marie Woodgate & Javier de Castro. (2018) Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study. BMC Health Services Research 18:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.